C. Nerl
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 10
- Blood disorders and treatments 2
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 6
-
- Immunodeficiency and Autoimmune Disorders 9
- Hematology top 10%
- Platelet Disorders and Treatments 2
- Dermatology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Vascular Tumors and Angiosarcomas 2
- Drug Transport and Resistance Mechanisms 2
C. Nerl
22 papers receiving 353 citations
Peers
Comparison fields: 5 of 55
- Genetics 134
- Pathology and Forensic Medicine 174
- Immunology 163
- Hematology 72
- Dermatology 49
Countries citing papers authored by C. Nerl
This map shows the geographic impact of C. Nerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Nerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Nerl more than expected).
Fields of papers citing papers by C. Nerl
This network shows the impact of papers produced by C. Nerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Nerl. The network helps show where C. Nerl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Nerl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 2 | |
| 2 | 2008 | 0 | |
| 3 | 2005 | 30 | |
| 4 | 2005 | 18 | |
| 5 | 2002 | 0 | |
| 6 | 1997 | 29 | |
| 7 | 1995 | 88 | |
| 8 | 1994 | 6 | |
| 9 | 1994 | 17 | |
| 10 | 1993 | 3 | |
| 11 | 1992 | 1 | |
| 12 | B-cell maturation in chronic lymphocytic leukaemia. IV. T-cell-dependent activation of leukaemic B cells by staphylococcal enterotoxin 'superantigens'. | 1992 | 3 |
| 13 | Recombinant human interferon-alpha in the treatment of angioimmunoblastic lymphadenopathy: results in 12 patients. | 1991 | 26 |
| 14 | [Lymphocyte subpopulations in patients with skin basalioma of the trunk]. | 1989 | 1 |
| 15 | 1989 | 9 | |
| 16 | Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients. | 1989 | 12 |
| 17 | B cell maturation in chronic lymphocytic leukemia. III. Effect of recombinant cytokines on leukemic B cell proliferation. | 1988 | 7 |
| 18 | 1987 | 13 | |
| 19 | 1985 | 47 | |
| 20 | 1978 | 9 |
About C. Nerl
C. Nerl is a scholar working on Genetics, Immunology and Hematology, having authored 24 papers that have together received 368 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (10 papers), Immunodeficiency and Autoimmune Disorders (9 papers), Lymphoma Diagnosis and Treatment (6 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Vascular Tumors and Angiosarcomas (2 papers), Platelet Disorders and Treatments (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Blood disorders and treatments (2 papers). The work is most often cited by research in Genetics (134 citations), Pathology and Forensic Medicine (174 citations) and Immunology (163 citations). C. Nerl has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Dieter Kabelitz, W. Siegert, K. Lennert, M. Engelhard, Markus Tiemann, Klaus Pfeffer, G. Brittinger, Alexander G Agthe, D. Huhn and Ottmar Janßen. Their work appears in journals such as Journal of Molecular Medicine, Diabetes, European Journal of Cancer, The Journal of Experimental Medicine and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.